<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedWire News - Thrombosis via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MedWire News - Thrombosis' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=MedWire+News+-+Thrombosis&t=MedWire+News+-+Thrombosis&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 09:15:14 +0100</lastBuildDate>
        <item>
            <title>Latest thrombosis guidelines issued by ACCP</title>
            <link>http://www.medworm.com/index.php?rid=5672317&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97386%2FThrombosis%2FLatest_thrombosis_guidelines_issued_by_ACCP.html</link>
            <description>The American College of Chest Physicians has published the 9th Edition of its “Antithrombotic Therapy and Prevention of Thrombosis” guidelines in Chest this week. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5672317</comments>
            <pubDate>Thu, 09 Feb 2012 13:58:35 +0100</pubDate>
            <guid isPermaLink="false">5672317</guid>        </item>
        <item>
            <title>Silent PE raises risk for early symptomatic PE in DVT patients</title>
            <link>http://www.medworm.com/index.php?rid=5663264&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97349%2FThrombosis%2FSilent_PE_raises_risk_for_early_symptomatic_PE_in_DVT_patients.html</link>
            <description>Patients with silent pulmonary embolism at the time of deep vein thrombosis diagnosis have an increased risk for symptomatic PE during the first 2 weeks of therapy, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663264</comments>
            <pubDate>Mon, 06 Feb 2012 13:46:06 +0100</pubDate>
            <guid isPermaLink="false">5663264</guid>        </item>
        <item>
            <title>Over 10% of lower extremity DVT cases isolated to calf</title>
            <link>http://www.medworm.com/index.php?rid=5654522&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97323%2FThrombosis%2FOver_10_of_lower_extremity_DVT_cases_isolated_to_calf.html</link>
            <description>More than one in 10 cases of lower extremity deep vein thrombosis are isolated to the distal calf, results of a community-based study show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654522</comments>
            <pubDate>Fri, 03 Feb 2012 14:08:27 +0100</pubDate>
            <guid isPermaLink="false">5654522</guid>        </item>
        <item>
            <title>VTE risk elevated in people with psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=5654523&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97237%2FThrombosis%2FVTE_risk_elevated_in_people_with_psoriasis.html</link>
            <description>People with psoriasis may have an increased risk for venous thromboembolism, results from a large study among US women suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654523</comments>
            <pubDate>Wed, 01 Feb 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654523</guid>        </item>
        <item>
            <title>Urinalysis should be routine in patients with VTE</title>
            <link>http://www.medworm.com/index.php?rid=5642305&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97184%2FThrombosis%2FUrinalysis_should_be_routine_in_patients_with_VTE.html</link>
            <description>US research shows that a “surprisingly high” proportion of patients with venous thromboembolism have proteinuria and nephrotic syndrome. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642305</comments>
            <pubDate>Mon, 30 Jan 2012 17:35:42 +0100</pubDate>
            <guid isPermaLink="false">5642305</guid>        </item>
        <item>
            <title>Length of compression stocking does not affect efficacy</title>
            <link>http://www.medworm.com/index.php?rid=5633695&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97167%2FThrombosis%2FLength_of_compression_stocking_does_not_affect_efficacy.html</link>
            <description>US researchers report that thigh-length compression stockings offer no increased protection against deep vein thrombosis over knee-length compression stockings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633695</comments>
            <pubDate>Fri, 27 Jan 2012 14:21:13 +0100</pubDate>
            <guid isPermaLink="false">5633695</guid>        </item>
        <item>
            <title>Improving vital signs should not lower clinical suspicion of PE</title>
            <link>http://www.medworm.com/index.php?rid=5633696&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97081%2FThrombosis%2FImproving_vital_signs_should_not_lower_clinical_suspicion_of_PE.html</link>
            <description>The return to normal of vital signs in emergency department patients does not mean that their risk for having pulmonary embolism has also subsided, warn US researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633696</comments>
            <pubDate>Wed, 25 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633696</guid>        </item>
        <item>
            <title>Western-style diet may increase VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5623635&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97050%2FThrombosis%2FWestern-style_diet_may_increase_VTE_risk.html</link>
            <description>A Western-style diet, high in red meat and trans fats, may be associated with an increased risk for venous thromboembolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623635</comments>
            <pubDate>Tue, 24 Jan 2012 14:22:03 +0100</pubDate>
            <guid isPermaLink="false">5623635</guid>        </item>
        <item>
            <title>Benchmark residual VTE risks for contemporary prophylaxis proposed</title>
            <link>http://www.medworm.com/index.php?rid=5615422&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F97016%2FThrombosis%2FBenchmark_residual_VTE_risks_for_contemporary_prophylaxis_proposed.html</link>
            <description>Approximately one in every 100 patients undergoing knee replacement and one in every 200 undergoing hip replacement will develop symptomatic venous thromboembolism prior to discharge, even though they receive thromboprophylaxis, researchers report in JAMA. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5615422</comments>
            <pubDate>Sat, 21 Jan 2012 13:59:11 +0100</pubDate>
            <guid isPermaLink="false">5615422</guid>        </item>
        <item>
            <title>VTE mortality risk persists long-term</title>
            <link>http://www.medworm.com/index.php?rid=5602521&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96951%2FThrombosis%2FVTE_mortality_risk_persists_long-term.html</link>
            <description>An increased risk for death may persist for up to 8 years among patients with a first venous thromboembolism, even when no comorbidities are present at the time of thrombosis, Dutch researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5602521</comments>
            <pubDate>Wed, 18 Jan 2012 15:01:39 +0100</pubDate>
            <guid isPermaLink="false">5602521</guid>        </item>
        <item>
            <title>Dabigatran linked to increased risk for MI, ACS</title>
            <link>http://www.medworm.com/index.php?rid=5602522&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96925%2FThrombosis%2FDabigatran_linked_to_increased_risk_for_MI%2C_ACS.html</link>
            <description>Dabigatran is associated with an increased risk for myocardial infarction or acute coronary syndrome, a meta-analysis suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5602522</comments>
            <pubDate>Tue, 17 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5602522</guid>        </item>
        <item>
            <title>Elevated albuminuria linked to increased recurrent VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5590762&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96850%2FThrombosis%2FElevated_albuminuria_linked_to_increased_recurrent_VTE_risk.html</link>
            <description>Individuals with an unprovoked venous thromboembolism who have elevated albuminuria are at increased risk for recurrence compared with those with normal urinary albumin levels, Dutch research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590762</comments>
            <pubDate>Sun, 15 Jan 2012 03:17:37 +0100</pubDate>
            <guid isPermaLink="false">5590762</guid>        </item>
        <item>
            <title>VTE risk raised in patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5590763&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96794%2FThrombosis%2FVTE_risk_raised_in_patients_with_rheumatoid_arthritis.html</link>
            <description>Individuals with rheumatoid arthritis are three times more likely to develop venous thromboembolism than people without the condition, US research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590763</comments>
            <pubDate>Wed, 11 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5590763</guid>        </item>
        <item>
            <title>AF may signal pulmonary embolism in patients with chest pain</title>
            <link>http://www.medworm.com/index.php?rid=5590764&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96772%2FThrombosis%2FAF_may_signal_pulmonary_embolism_in_patients_with_chest_pain.html</link>
            <description>Study findings suggest that having atrial fibrillation does not increase the likelihood for a pulmonary embolism diagnosis, except in patients presenting with chest pain. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5590764</comments>
            <pubDate>Mon, 09 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5590764</guid>        </item>
        <item>
            <title>Adverse event risk lasts at least 5 years with sirolimus-eluting stents</title>
            <link>http://www.medworm.com/index.php?rid=5566985&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96741%2FThrombosis%2FAdverse_event_risk_lasts_at_least_5_years_with_sirolimus-eluting_stents_.html</link>
            <description>Late adverse events such as very late stent thrombosis and late target lesion revascularization pose a threat to patients for at least 5 years after implantation of a first generation drug-eluting stent, Japanese study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566985</comments>
            <pubDate>Fri, 06 Jan 2012 18:56:24 +0100</pubDate>
            <guid isPermaLink="false">5566985</guid>        </item>
        <item>
            <title>Enoxaparin does not reduce mortality in acutely ill medical patients</title>
            <link>http://www.medworm.com/index.php?rid=5566986&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96694%2FThrombosis%2FEnoxaparin_does_not_reduce_mortality_in_acutely_ill_medical_patients.html</link>
            <description>Pharmacologic thromboprophylaxis with the low molecular weight heparin enoxaparin does not reduce mortality among hospitalized acutely ill medical patients already using elastic stockings with compression, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566986</comments>
            <pubDate>Thu, 05 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566986</guid>        </item>
        <item>
            <title>Catheter-directed mechanical thrombectomy ‘highly successful’ for PE</title>
            <link>http://www.medworm.com/index.php?rid=5566988&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96646%2FThrombosis%2FCatheter-directed_mechanical_thrombectomy_%E2%80%98highly_successful%E2%80%99_for_PE.html</link>
            <description>Catheter-directed mechanical thrombectomy is highly successful for the treatment of pulmonary embolism in both normal- and high-risk patients, say US surgeons. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566988</comments>
            <pubDate>Tue, 03 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566988</guid>        </item>
        <item>
            <title>Insufficient evidence to support genetic testing before clopidogrel use</title>
            <link>http://www.medworm.com/index.php?rid=5566987&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96640%2FThrombosis%2FInsufficient_evidence_to_support_genetic_testing_before_clopidogrel_use.html</link>
            <description>There is insufficient evidence to support genetic testing before prescribing clopidogrel, say UK researchers whose review found no conclusive proof of a clinically important association between CYP2C19 genotype and the effect of clopidogrel on cardiovascular outcomes. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566987</comments>
            <pubDate>Tue, 03 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566987</guid>        </item>
        <item>
            <title>VTE risk in pregnancy remains high after delivery</title>
            <link>http://www.medworm.com/index.php?rid=5541533&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96581%2FThrombosis%2FVTE_risk_in_pregnancy_remains_high_after_delivery.html</link>
            <description>UK study results show that the increased risk for venous thromboembolism associated with pregnancy is highest in the third trimester and remains elevated until 3 weeks postpartum. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5541533</comments>
            <pubDate>Mon, 26 Dec 2011 02:28:20 +0100</pubDate>
            <guid isPermaLink="false">5541533</guid>        </item>
        <item>
            <title>RECOVER II confirms dabigatran efficacy in VTE</title>
            <link>http://www.medworm.com/index.php?rid=5531192&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96550%2FThrombosis%2FRECOVER_II_confirms_dabigatran_efficacy_in_VTE.html</link>
            <description>Results from the RECOVER II trial confirm that dabigatran is non-inferior to that of warfarin in the treatment of acute venous thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531192</comments>
            <pubDate>Fri, 23 Dec 2011 03:05:29 +0100</pubDate>
            <guid isPermaLink="false">5531192</guid>        </item>
        <item>
            <title>Low iron levels linked to increased VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5519459&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96469%2FThrombosis%2FLow_iron_levels_linked_to_increased_VTE_risk.html</link>
            <description>Low serum iron levels are associated with an increased risk for venous thromboembolism, a study of patients with hereditary hemorrhagic telangiectasia shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5519459</comments>
            <pubDate>Tue, 20 Dec 2011 02:10:39 +0100</pubDate>
            <guid isPermaLink="false">5519459</guid>        </item>
        <item>
            <title>Computerized reminders improve VTE prophylaxis rates</title>
            <link>http://www.medworm.com/index.php?rid=5531193&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96503%2FThrombosis%2FComputerized_reminders_improve_VTE_prophylaxis_rates.html</link>
            <description>A computerized decision-making tool that reminds physicians to order venous thromboembolism prophylaxis reduces the rate of post-hospital discharge thrombosis without increasing bleeding, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5531193</comments>
            <pubDate>Tue, 20 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5531193</guid>        </item>
        <item>
            <title>Heart-healthy diet does not reduce VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5510533&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96451%2FThrombosis%2FHeart-healthy_diet_does_not_reduce_VTE_risk.html</link>
            <description>Following a diet that is high in fruits, vegetables, and low-fat dairy products, but low in saturated and total fat does not reduce the risk for venous thromboembolism in women, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510533</comments>
            <pubDate>Sat, 17 Dec 2011 02:26:41 +0100</pubDate>
            <guid isPermaLink="false">5510533</guid>        </item>
        <item>
            <title>Catheter-directed thrombolysis prevents post-thrombotic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5510534&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96420%2FThrombosis%2FCatheter-directed_thrombolysis_prevents_post-thrombotic_syndrome.html</link>
            <description>Catheter-directed thrombolysis significantly reduces the incidence of post-thrombotic syndrome after iliofemoral deep vein thrombosis compared with conventional treatment with anticoagulation and elastic compression stockings, Norwegian research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5510534</comments>
            <pubDate>Thu, 15 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5510534</guid>        </item>
        <item>
            <title>Outpatient primary care PE treatment effective</title>
            <link>http://www.medworm.com/index.php?rid=5499830&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96369%2FThrombosis%2FOutpatient_primary_care_PE_treatment_effective.html</link>
            <description>The majority of patients with pulmonary embolism can be cared for as outpatients by their primary care physician, suggest findings from a review showing that nearly half of patients are candidates for immediate discharge. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499830</comments>
            <pubDate>Wed, 14 Dec 2011 03:26:17 +0100</pubDate>
            <guid isPermaLink="false">5499830</guid>        </item>
        <item>
            <title>Premature heparin re-initiation during bridging therapy puts patients at risk</title>
            <link>http://www.medworm.com/index.php?rid=5499831&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96340%2FThrombosis%2FPremature_heparin_re-initiation_during_bridging_therapy_puts_patients_at_risk.html</link>
            <description>Premature re-initiation of therapeutic heparin within 24 hours of surgery is an independent risk factor for a major bleeding event among chronically anticoagulated patients requiring temporary warfarin interruption for invasive procedures, show study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5499831</comments>
            <pubDate>Mon, 12 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5499831</guid>        </item>
        <item>
            <title>High D-dimer levels increase risk for early death in acute PE patients</title>
            <link>http://www.medworm.com/index.php?rid=5491371&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96325%2FThrombosis%2FHigh_D-dimer_levels_increase_risk_for_early_death_in_acute_PE_patients.html</link>
            <description>Results from a systematic review and meta-analysis suggest that patients with acute pulmonary embolism and high levels of D-dimer are significantly more likely to die within 3 months than patients with low D-dimer levels. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5491371</comments>
            <pubDate>Sun, 11 Dec 2011 03:21:24 +0100</pubDate>
            <guid isPermaLink="false">5491371</guid>        </item>
        <item>
            <title>Idrabiotaparinux ‘expands armentarium’ against VTE</title>
            <link>http://www.medworm.com/index.php?rid=5481615&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96266%2FThrombosis%2FIdrabiotaparinux_%E2%80%98expands_armentarium%E2%80%99_against_VTE.html</link>
            <description>Idrabiotaparinux appears to be a good alternative to warfarin as an add-on therapy to enoxaparin for treatment of patients with pulmonary embolism, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481615</comments>
            <pubDate>Thu, 08 Dec 2011 02:49:34 +0100</pubDate>
            <guid isPermaLink="false">5481615</guid>        </item>
        <item>
            <title>Cilostazol improves clopidogrel platelet inhibitory effect in CKD patients</title>
            <link>http://www.medworm.com/index.php?rid=5481616&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96236%2FThrombosis%2FCilostazol_improves_clopidogrel_platelet_inhibitory_effect_in_CKD_patients.html</link>
            <description>Adding cilostazol to antiplatelet therapy improves platelet inhibition in patients with chronic kidney disease undergoing hemodialysis, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481616</comments>
            <pubDate>Wed, 07 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5481616</guid>        </item>
        <item>
            <title>Clopidogrel more effective in CYP2C19*17 carriers</title>
            <link>http://www.medworm.com/index.php?rid=5481617&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96224%2FThrombosis%2FClopidogrel_more_effective_in_CYP2C1917_carriers_.html</link>
            <description>Individuals with coronary artery disease who carry the CYP2C19*17 allele variant respond better to clopidogrel’s cardioprotective effects than those who do not carry the variant, Chinese researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5481617</comments>
            <pubDate>Tue, 06 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5481617</guid>        </item>
        <item>
            <title>Warfarin self-monitoring ‘superior’ to conventional care</title>
            <link>http://www.medworm.com/index.php?rid=5472759&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96178%2FThrombosis%2FWarfarin_self-monitoring_%E2%80%98superior%E2%80%99_to_conventional_care.html</link>
            <description>Self-monitoring of oral anticoagulation therapy is superior to conventional care, a meta-analysis published in The Lancet reveals. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5472759</comments>
            <pubDate>Mon, 05 Dec 2011 02:58:46 +0100</pubDate>
            <guid isPermaLink="false">5472759</guid>        </item>
        <item>
            <title>Point-of-care INR monitors acceptable for clinical use</title>
            <link>http://www.medworm.com/index.php?rid=5463535&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96164%2FThrombosis%2FPoint-of-care_INR_monitors_acceptable_for_clinical_use.html</link>
            <description>Point-of-care monitors to assess the effectiveness of oral anticoagulant therapy are &quot;adequate&quot; for estimating the international normalized ratio, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463535</comments>
            <pubDate>Fri, 02 Dec 2011 03:00:47 +0100</pubDate>
            <guid isPermaLink="false">5463535</guid>        </item>
        <item>
            <title>NICE Fast-tracks Apixaban for postsurgery VTE prevention</title>
            <link>http://www.medworm.com/index.php?rid=5463536&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96131%2FThrombosis%2FNICE_Fast-tracks_Apixaban_for_postsurgery_VTE_prevention.html</link>
            <description>The UK National Institute for Health and Clinical Excellence has published final draft guidance recommending apixaban for the prevention of venous thromboembolism in adults who have undergone planned total hip or knee replacement surgery. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463536</comments>
            <pubDate>Thu, 01 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463536</guid>        </item>
        <item>
            <title>Autoimmune disease linked to increased pulmonary embolism risk</title>
            <link>http://www.medworm.com/index.php?rid=5452988&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96048%2FThrombosis%2FAutoimmune_disease_linked_to_increased_pulmonary_embolism_risk.html</link>
            <description>People admitted to hospital with an autoimmune disorder have a high risk for pulmonary embolism in the year after admission, Swedish study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5452988</comments>
            <pubDate>Tue, 29 Nov 2011 02:52:28 +0100</pubDate>
            <guid isPermaLink="false">5452988</guid>        </item>
        <item>
            <title>IV iron may reduce thromboembolism risk in chemotherapy patients</title>
            <link>http://www.medworm.com/index.php?rid=5463537&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96088%2FThrombosis%2FIV_iron_may_reduce_thromboembolism_risk_in_chemotherapy_patients.html</link>
            <description>Administering intravenous iron may reduce the risk for venous thromboembolism in patients with chemotherapy induced anemia, US study findings suggest. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5463537</comments>
            <pubDate>Tue, 29 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5463537</guid>        </item>
        <item>
            <title>CHA2DS2-VASc best predictor of AF complications</title>
            <link>http://www.medworm.com/index.php?rid=5446317&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F96034%2FThrombosis%2FCHA2DS2-VASc_best_predictor_of_AF_complications.html</link>
            <description>The CHA2DS2-VASc risk score may be the most accurate of four contemporary risk models in identifying patients with atrial fibrillation at greatest risk for thromboembolic complications, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446317</comments>
            <pubDate>Sat, 26 Nov 2011 02:35:53 +0100</pubDate>
            <guid isPermaLink="false">5446317</guid>        </item>
        <item>
            <title>Incidence of silent abdominal DVT ‘not negligible’</title>
            <link>http://www.medworm.com/index.php?rid=5446318&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95985%2FThrombosis%2FIncidence_of_silent_abdominal_DVT_%E2%80%98not_negligible%E2%80%99.html</link>
            <description>Nearly 2% of patients undergoing abdominal computed tomography scan have clinically silent abdominal deep vein thrombosis, Italian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5446318</comments>
            <pubDate>Thu, 24 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5446318</guid>        </item>
        <item>
            <title>Aspirin reduces recurrent VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5436024&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95943%2FThrombosis%2FAspirin_reduces_recurrent_VTE_risk.html</link>
            <description>Aspirin reduces the risk for recurrent venous thromboembolism by about 40% in patients with an unprovoked first event, when given after 6 to 12 months of anticoagulant treatment, Italian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5436024</comments>
            <pubDate>Wed, 23 Nov 2011 02:17:50 +0100</pubDate>
            <guid isPermaLink="false">5436024</guid>        </item>
        <item>
            <title>High-sensitivity troponin T assay identifies early discharge PE patients</title>
            <link>http://www.medworm.com/index.php?rid=5436025&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95897%2FThrombosis%2FHigh-sensitivity_troponin_T_assay_identifies_early_discharge_PE_patients_.html</link>
            <description>A high-sensitivity troponin T assay accurately identifies patients with low-risk pulmonary embolism, and may be helpful for selecting possible candidates for early discharge and home treatment, say researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5436025</comments>
            <pubDate>Mon, 21 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5436025</guid>        </item>
        <item>
            <title>Triple-dose clopidogrel overcomes resistance in some patients</title>
            <link>http://www.medworm.com/index.php?rid=5426870&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95873%2FThrombosis%2FTriple-dose_clopidogrel_overcomes_resistance_in_some_patients_.html</link>
            <description>Using a triple dose of clopidogrel may overcome the blunted response to the drug seen in some patients with genetic variants in CYP2C19, a study suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426870</comments>
            <pubDate>Sun, 20 Nov 2011 02:29:00 +0100</pubDate>
            <guid isPermaLink="false">5426870</guid>        </item>
        <item>
            <title>Raised blood sugar linked to poor prognosis in PE</title>
            <link>http://www.medworm.com/index.php?rid=5426871&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95881%2FThrombosis%2FRaised_blood_sugar_linked_to_poor_prognosis_in_PE.html</link>
            <description>More than half of patients with pulmonary embolism have an elevated blood glucose level at the time of presentation, which puts them at increased risk for short-term mortality, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426871</comments>
            <pubDate>Fri, 18 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426871</guid>        </item>
        <item>
            <title>Three-monthly warfarin assessment ‘feasible’</title>
            <link>http://www.medworm.com/index.php?rid=5415364&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95835%2FThrombosis%2FThree-monthly_warfarin_assessment_%E2%80%98feasible%E2%80%99.html</link>
            <description>Assessment of warfarin dosing every 3 months is not inferior to monthly assessment in terms of the percentage of time spent in the therapeutic international normalized ratio range, Canadian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415364</comments>
            <pubDate>Thu, 17 Nov 2011 17:01:50 +0100</pubDate>
            <guid isPermaLink="false">5415364</guid>        </item>
        <item>
            <title>High CHADS2 also predicts bleeding, mortality</title>
            <link>http://www.medworm.com/index.php?rid=5415368&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95788%2FThrombosis%2FHigh_CHADS2_also_predicts_bleeding%2C_mortality.html</link>
            <description>The CHADS2 score predicts the risk for bleeding, intracranial bleeding, and mortality, as well as stroke, in patients with atrial fibrillation, shows an analysis of the RE-LY trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415368</comments>
            <pubDate>Tue, 15 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415368</guid>        </item>
        <item>
            <title>VerifyNow P2Y12 assay influenced by CYP2C9 variants</title>
            <link>http://www.medworm.com/index.php?rid=5415367&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95787%2FThrombosis%2FVerifyNow_P2Y12_assay_influenced_by_CYP2C9_variants.html</link>
            <description>Loss-of-function variants in cytochrome P450 2C9 are associated with decreased clopidogrel-mediated platelet inhibition and an increased rate of high on-treatment residual platelet reactivity by the VerifyNow P2Y12 assay, Austrian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415367</comments>
            <pubDate>Tue, 15 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415367</guid>        </item>
        <item>
            <title>Apixaban no more effective than enoxaparin in preventing VTE</title>
            <link>http://www.medworm.com/index.php?rid=5415366&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95778%2FThrombosis%2FApixaban_no_more_effective_than_enoxaparin_in_preventing_VTE.html</link>
            <description>An extended course of thromboprophylaxis with apixaban is no more effective in preventing venous thromboembolism in medically ill patients than a shorter course of enoxaparin, suggest the results of the ADOPT trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415366</comments>
            <pubDate>Tue, 15 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415366</guid>        </item>
        <item>
            <title>Rivaroxaban reduces risk for death from CV cause, MI, or stroke in ACS</title>
            <link>http://www.medworm.com/index.php?rid=5415365&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95776%2FThrombosis%2FRivaroxaban_reduces_risk_for_death_from_CV_cause%2C_MI%2C_or_stroke_in_ACS.html</link>
            <description>The factor Xa inhibitor rivaroxaban significantly reduces the incidence of death from cardiovascular causes, myocardial infarction, or stroke in patients with a recent acute coronary syndrome, show results of the ATLAS ACS 2-TIMI 51 trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415365</comments>
            <pubDate>Tue, 15 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415365</guid>        </item>
        <item>
            <title>Atherosclerotic risk factors not linked to VTE</title>
            <link>http://www.medworm.com/index.php?rid=5403977&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95742%2FThrombosis%2FAtherosclerotic_risk_factors_not_linked_to_VTE.html</link>
            <description>Traditional atherosclerotic risk factors such as male gender, hypertension, dyslipidemia, diabetes, and smoking are not shared by arterial and venous thrombosis, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5403977</comments>
            <pubDate>Mon, 14 Nov 2011 01:36:59 +0100</pubDate>
            <guid isPermaLink="false">5403977</guid>        </item>
        <item>
            <title>Bivalirudin preferred for PCI in AMI with or without ST-elevation</title>
            <link>http://www.medworm.com/index.php?rid=5415371&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95775%2FThrombosis%2FBivalirudin_preferred_for_PCI_in_AMI_with_or_without_ST-elevation_.html</link>
            <description>A head-to-head comparison of a combination of abciximab and unfractionated heparin versus bivalirudin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention shows that the efficacy of the two therapies are virtually identical. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415371</comments>
            <pubDate>Mon, 14 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415371</guid>        </item>
        <item>
            <title>Intracoronary abciximab no better than intravenous delivery for STEMI treatment</title>
            <link>http://www.medworm.com/index.php?rid=5415370&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95774%2FThrombosis%2FIntracoronary_abciximab_no_better_than_intravenous_delivery_for_STEMI_treatment_.html</link>
            <description>Intracoronary administration of the glycoprotein IIb/IIIa inhibitor abciximab does not improve overall health outcomes over intravenous delivery in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention, show results from the AIDA STEMI trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415370</comments>
            <pubDate>Mon, 14 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415370</guid>        </item>
        <item>
            <title>Warfarin use raises IVH risk, severity in event of ICH</title>
            <link>http://www.medworm.com/index.php?rid=5415369&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95770%2FThrombosis%2FWarfarin_use_raises_IVH_risk%2C_severity_in_event_of_ICH.html</link>
            <description>Warfarin worsens intracerebral hemorrhage outcomes by affecting intraventricular hemorrhage risk and severity, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5415369</comments>
            <pubDate>Mon, 14 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5415369</guid>        </item>
        <item>
            <title>VTE risk low after knee surgery in Taiwan</title>
            <link>http://www.medworm.com/index.php?rid=5394402&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95713%2FThrombosis%2FVTE_risk_low_after_knee_surgery_in_Taiwan.html</link>
            <description>The rate of symptomatic venous thromboembolism after knee replacement surgery is low in patients from Taiwan, in spite of a low rate of thromboprophylaxis, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394402</comments>
            <pubDate>Fri, 11 Nov 2011 03:08:09 +0100</pubDate>
            <guid isPermaLink="false">5394402</guid>        </item>
        <item>
            <title>Phenprocoumon useful in the treatment of aortic valve thrombosis</title>
            <link>http://www.medworm.com/index.php?rid=5394403&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95695%2FThrombosis%2FPhenprocoumon_useful_in_the_treatment_of_aortic_valve_thrombosis.html</link>
            <description>Phenprocoumon represents a suitable alternative to surgery or thrombolysis for the treatment of obstructive bioprosthetic valve thrombosis in hemodynamically stable patients, German researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394403</comments>
            <pubDate>Thu, 10 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394403</guid>        </item>
        <item>
            <title>Further data highlight drospirenone-associated VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5394404&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95643%2FThrombosis%2FFurther_data_highlight_drospirenone-associated_VTE_risk_.html</link>
            <description>Drospirenone-containing oral contraceptives confer a greater risk for deep vein thrombosis and pulmonary embolism than second- and third-generation combined oral contraceptives that do not contain drosipirenone, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394404</comments>
            <pubDate>Tue, 08 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394404</guid>        </item>
        <item>
            <title>VTE common in hospitalized COPD patients</title>
            <link>http://www.medworm.com/index.php?rid=5394405&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95622%2FThrombosis%2FVTE_common_in_hospitalized_COPD_patients.html</link>
            <description>Approximately one in 100 patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease develops venous thromboembolism during their hospital stay, Spanish study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5394405</comments>
            <pubDate>Mon, 07 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5394405</guid>        </item>
        <item>
            <title>Cytokine polymorphisms not linked to VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5371933&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95589%2FThrombosis%2FCytokine_polymorphisms_not_linked_to_VTE_risk.html</link>
            <description>Polymorphisms in genes encoding the inflammatory cytokines interleukin 6, interleukin 8, and monocyte chemotactic protein-1 are not associated with risk for venous thromboembolism, Brazilian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371933</comments>
            <pubDate>Fri, 04 Nov 2011 11:16:14 +0100</pubDate>
            <guid isPermaLink="false">5371933</guid>        </item>
        <item>
            <title>Routine VTE prophylaxis in medical patients not supported by the ACP</title>
            <link>http://www.medworm.com/index.php?rid=5371934&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95563%2FThrombosis%2FRoutine_VTE_prophylaxis_in_medical_patients_not_supported_by_the_ACP.html</link>
            <description>Doctors should assess the risk for venous thromboembolism and bleeding in patients hospitalized for medical illnesses including stroke, before initiating thromboprophylaxis, state guidelines from the American College of Physicians. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371934</comments>
            <pubDate>Thu, 03 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371934</guid>        </item>
        <item>
            <title>ApoE polymorphism raises DVT risk in women not men</title>
            <link>http://www.medworm.com/index.php?rid=5371935&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95508%2FThrombosis%2FApoE_polymorphism_raises_DVT_risk_in_women_not_men.html</link>
            <description>Women with the apolipoprotein E ε2 allele are at increased risk for deep vein thrombosis, Brazilian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371935</comments>
            <pubDate>Tue, 01 Nov 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371935</guid>        </item>
        <item>
            <title>Progestogen type impacts VTE risk associated with contraceptive pills</title>
            <link>http://www.medworm.com/index.php?rid=5371936&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95478%2FThrombosis%2FProgestogen_type_impacts_VTE_risk_associated_with_contraceptive_pills_.html</link>
            <description>Women taking contraceptive pills containing one of the newer types of progestogen hormone, namely drospirenone, desogestrel, or gestodene, have twice the risk for venous thromboembolism as those on pills containing the older progestogen levonorgestrel, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371936</comments>
            <pubDate>Mon, 31 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371936</guid>        </item>
        <item>
            <title>NICE thrombosis guidelines open for consultation</title>
            <link>http://www.medworm.com/index.php?rid=5371937&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95444%2FThrombosis%2FNICE_thrombosis_guidelines_open_for_consultation.html</link>
            <description>The UK National Institute for Health and Clinical Excellence has issued a draft guideline on the management of venous thromboembolic diseases in adults with suspected of confirmed deep vein thrombosis or pulmonary embolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5371937</comments>
            <pubDate>Fri, 28 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5371937</guid>        </item>
        <item>
            <title>Early stent thrombosis predictors identified</title>
            <link>http://www.medworm.com/index.php?rid=5353602&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95425%2FThrombosis%2FEarly_stent_thrombosis_predictors_identified.html</link>
            <description>Variants in three genes associated with clopidogrel metabolism and platelet receptor function are independently associated with early stent thrombosis in patients undergoing percutaneous coronary intervention, study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353602</comments>
            <pubDate>Thu, 27 Oct 2011 14:48:29 +0100</pubDate>
            <guid isPermaLink="false">5353602</guid>        </item>
        <item>
            <title>Thromboelastography reference ranges unsuitable for pregnant women</title>
            <link>http://www.medworm.com/index.php?rid=5353603&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95371%2FThrombosis%2FThromboelastography_reference_ranges_unsuitable_for_pregnant_women.html</link>
            <description>The use of standard reference ranges for thromboelastography parameters may not be suitable for pregnant women, and could lead to the misinterpretation of the coagulation state, Czech researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353603</comments>
            <pubDate>Tue, 25 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353603</guid>        </item>
        <item>
            <title>Operable and inoperable CTEPH similar but different</title>
            <link>http://www.medworm.com/index.php?rid=5353604&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95345%2FThrombosis%2FOperable_and_inoperable_CTEPH_similar_but_different.html</link>
            <description>Patients with operable and inoperable chronic thromboembolic pulmonary hypertension present with similar symptoms but differ in terms of related medical conditions, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5353604</comments>
            <pubDate>Mon, 24 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5353604</guid>        </item>
        <item>
            <title>Lipid parameters linked to venous thromboembolism risk</title>
            <link>http://www.medworm.com/index.php?rid=5341964&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95314%2FThrombosis%2FLipid_parameters_linked_to_venous_thromboembolism_risk.html</link>
            <description>Study findings suggest that levels of lipids and lipoproteins may contribute to the development of venous thromboembolism among patients not using lipid-lowering drugs. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5341964</comments>
            <pubDate>Sun, 23 Oct 2011 17:53:30 +0100</pubDate>
            <guid isPermaLink="false">5341964</guid>        </item>
        <item>
            <title>Thrombotic complication rates ‘low’ during pediatric cardiac catheterization</title>
            <link>http://www.medworm.com/index.php?rid=5341965&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95321%2FThrombosis%2FThrombotic_complication_rates_%E2%80%98low%E2%80%99_during_pediatric_cardiac_catheterization.html</link>
            <description>The rates of thrombotic events and bleeding complications are low among children undergoing cardiac catheterization, irrespective of whether they are given low- or high-dose unfractionated heparin as thromboprophylaxis, Austrian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5341965</comments>
            <pubDate>Fri, 21 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5341965</guid>        </item>
        <item>
            <title>Trunk obesity linked to increased thrombin generation</title>
            <link>http://www.medworm.com/index.php?rid=5341966&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95282%2FThrombosis%2FTrunk_obesity_linked_to_increased_thrombin_generation.html</link>
            <description>Trunk obesity, low-grade inflammation, and hypercholesterolemia are all significantly associated with enhanced thrombin generation, Austrian research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5341966</comments>
            <pubDate>Thu, 20 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5341966</guid>        </item>
        <item>
            <title>Inflammatory bowel disease patients have increased postsurgery VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5328959&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95229%2FThrombosis%2FInflammatory_bowel_disease_patients_have_increased_postsurgery_VTE_risk_.html</link>
            <description>Patients with inflammatory bowel disease have twice the risk for postoperative venous thromboembolism as patients without the condition, US research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5328959</comments>
            <pubDate>Wed, 19 Oct 2011 12:45:26 +0100</pubDate>
            <guid isPermaLink="false">5328959</guid>        </item>
        <item>
            <title>Post-anticoagulation imaging helps predict VTE recurrence</title>
            <link>http://www.medworm.com/index.php?rid=5328960&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95216%2FThrombosis%2FPost-anticoagulation_imaging_helps_predict_VTE_recurrence.html</link>
            <description>Imaging conducted after completion of anticoagulant therapy for unprovoked deep vein thrombosis or pulmonary embolism aids diagnosis in cases of suspected recurrent venous thromboembolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5328960</comments>
            <pubDate>Mon, 17 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5328960</guid>        </item>
        <item>
            <title>Australia issues bleeding warning for dabigatran</title>
            <link>http://www.medworm.com/index.php?rid=5320067&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95175%2FThrombosis%2FAustralia_issues_bleeding_warning_for_dabigatran.html</link>
            <description>Australia’s regulatory authority for therapeutic goods, the Therapeutic Goods Administration (), has issued a safety advisory for the oral anticoagulant dabigatran following increased reports of adverse events. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5320067</comments>
            <pubDate>Sun, 16 Oct 2011 04:38:43 +0100</pubDate>
            <guid isPermaLink="false">5320067</guid>        </item>
        <item>
            <title>Cumulative flight time impacts VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5309401&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95159%2FThrombosis%2FCumulative_flight_time_impacts_VTE_risk.html</link>
            <description>A cumulative flying time of more than 12 hours within 28 days is associated with a similar risk for venous thromboembolism as a single long-haul flight, UK research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5309401</comments>
            <pubDate>Thu, 13 Oct 2011 03:43:50 +0100</pubDate>
            <guid isPermaLink="false">5309401</guid>        </item>
        <item>
            <title>PLA2G7 polymorphism may increase thrombosis risk in men with high BP</title>
            <link>http://www.medworm.com/index.php?rid=5309402&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95115%2FThrombosis%2FPLA2G7_polymorphism_may_increase_thrombosis_risk_in_men_with_high_BP.html</link>
            <description>A polymorphism in the gene encoding lipoprotein-associated phospholipase A2 is associated with increased thrombotic burden in men with hypertension, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5309402</comments>
            <pubDate>Tue, 11 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5309402</guid>        </item>
        <item>
            <title>Prothrombin complex concentrate may reverse rivaroxaban anticoagulation</title>
            <link>http://www.medworm.com/index.php?rid=5300891&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95072%2FThrombosis%2FProthrombin_complex_concentrate_may_reverse_rivaroxaban_anticoagulation.html</link>
            <description>Prothrombin complex concentrate may reverse the anticoagulant effects of the factor Xa inhibitor rivaroxaban, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5300891</comments>
            <pubDate>Mon, 10 Oct 2011 02:05:51 +0100</pubDate>
            <guid isPermaLink="false">5300891</guid>        </item>
        <item>
            <title>Outpatient care could reduce DVT-related costs</title>
            <link>http://www.medworm.com/index.php?rid=5291343&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95041%2FThrombosis%2FOutpatient_care_could_reduce_DVT-related_costs.html</link>
            <description>Favoring outpatient over inpatient care and taking measures to prevent occurrence of post-thrombotic syndrome have the potential to reduce the substantial costs associated with deep vein thrombosis, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5291343</comments>
            <pubDate>Fri, 07 Oct 2011 01:59:02 +0100</pubDate>
            <guid isPermaLink="false">5291343</guid>        </item>
        <item>
            <title>Antiproteinuric therapy reduces prothrombotic state in certain patients</title>
            <link>http://www.medworm.com/index.php?rid=5291344&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F95015%2FThrombosis%2FAntiproteinuric_therapy_reduces_prothrombotic_state_in_certain_patients_.html</link>
            <description>Antiproteinuric therapy reverses the prothrombotic state in patients with overt proteinuria and stable renal function, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5291344</comments>
            <pubDate>Thu, 06 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5291344</guid>        </item>
        <item>
            <title>Fondaparinux effective treatment for SRA-positive HIT</title>
            <link>http://www.medworm.com/index.php?rid=5279919&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94953%2FThrombosis%2FFondaparinux_effective_treatment_for_SRA-positive_HIT.html</link>
            <description>Patients with acute immune heparin-induced thrombocytopenia, confirmed by serotonin-release assay, may benefit from anticoagulant treatment with fondaparinux, suggest study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5279919</comments>
            <pubDate>Tue, 04 Oct 2011 01:42:35 +0100</pubDate>
            <guid isPermaLink="false">5279919</guid>        </item>
        <item>
            <title>Cause of death classification influences PE risk predictors</title>
            <link>http://www.medworm.com/index.php?rid=5279920&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94943%2FThrombosis%2FCause_of_death_classification_influences_PE_risk_predictors.html</link>
            <description>Cause of death classification significantly influences the prognostic performance of the biomarker cardiac troponin I, but not the clinical simplified Pulmonary Embolism Severity Index in patients with pulmonary embolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5279920</comments>
            <pubDate>Mon, 03 Oct 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5279920</guid>        </item>
        <item>
            <title>VTE costly in cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=5266750&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94913%2FThrombosis%2FVTE_costly_in_cancer_patients.html</link>
            <description>Venous thromboembolism is a common complication among patients receiving chemotherapy, and is associated with a significant economic burden, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266750</comments>
            <pubDate>Fri, 30 Sep 2011 04:16:57 +0100</pubDate>
            <guid isPermaLink="false">5266750</guid>        </item>
        <item>
            <title>CTEPH phenotype associated with existence, type of DVT</title>
            <link>http://www.medworm.com/index.php?rid=5266751&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94870%2FThrombosis%2FCTEPH_phenotype_associated_with_existence%2C_type_of_DVT.html</link>
            <description>The clinical phenotype of chronic thromboembolic pulmonary hypertension is associated with the existence and type of deep vein thrombosis, suggest study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266751</comments>
            <pubDate>Thu, 29 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266751</guid>        </item>
        <item>
            <title>VTE risk linked to occupation, socioeconomic status</title>
            <link>http://www.medworm.com/index.php?rid=5266752&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94831%2FThrombosis%2FVTE_risk_linked_to_occupation%2C_socioeconomic_status.html</link>
            <description>The risk for venous thromboembolism varies by occupation and socioeconomic status, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5266752</comments>
            <pubDate>Tue, 27 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5266752</guid>        </item>
        <item>
            <title>Thrombosis common complication in child heart surgery patients</title>
            <link>http://www.medworm.com/index.php?rid=5256080&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94809%2FThrombosis%2FThrombosis_common_complication_in_child_heart_surgery_patients.html</link>
            <description>The incidence of thrombosis in pediatric cardiac surgery patients has been previously underestimated, according to research published the journal Circulation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256080</comments>
            <pubDate>Mon, 26 Sep 2011 18:52:55 +0100</pubDate>
            <guid isPermaLink="false">5256080</guid>        </item>
        <item>
            <title>Historic VTE risk factors do not impact recurrence risk</title>
            <link>http://www.medworm.com/index.php?rid=5244588&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94770%2FThrombosis%2FHistoric_VTE_risk_factors_do_not_impact_recurrence_risk.html</link>
            <description>Asking a patient about past exposure to venous thrombosis risk factors long before the occurrence of a first venous thrombosis occurred does not help predict their risk for recurrence, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5244588</comments>
            <pubDate>Fri, 23 Sep 2011 03:14:48 +0100</pubDate>
            <guid isPermaLink="false">5244588</guid>        </item>
        <item>
            <title>MACCE risk from OAT interruption may outweigh bleeding benefit</title>
            <link>http://www.medworm.com/index.php?rid=5256081&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94802%2FThrombosis%2FMACCE_risk_from_OAT_interruption_may_outweigh_bleeding_benefit.html</link>
            <description>Patients with coronary stents undergoing an invasive procedure have a high risk for a perioperative major adverse cardiac and cerebrovascular event after interruption of oral antiplatelet therapy, say French scientists. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5256081</comments>
            <pubDate>Fri, 23 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5256081</guid>        </item>
        <item>
            <title>Enoxaparin thromboprophylaxis benefits hospitalized medical patients</title>
            <link>http://www.medworm.com/index.php?rid=5244589&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94752%2FThrombosis%2FEnoxaparin_thromboprophylaxis_benefits_hospitalized_medical_patients.html</link>
            <description>Prophylactic enoxaparin is associated with a reduced incidence of symptomatic venous thromboembolism and in-hospital mortality, without increasing the risk for bleeding or thrombocytopenia, a study in hospitalized medical patients has shown. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5244589</comments>
            <pubDate>Thu, 22 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5244589</guid>        </item>
        <item>
            <title>Clot architecture is altered in patients with abdominal aortic aneurysm</title>
            <link>http://www.medworm.com/index.php?rid=5244590&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94694%2FThrombosis%2FClot_architecture_is_altered_in_patients_with_abdominal_aortic_aneurysm.html</link>
            <description>Patients with abdominal aortic aneurysm form denser, smaller-pored plasma clots that are more resistant to fibrinolysis than individuals without the condition, UK research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5244590</comments>
            <pubDate>Tue, 20 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5244590</guid>        </item>
        <item>
            <title>VTE risk varies according to glomerulonephritis histologic subtype</title>
            <link>http://www.medworm.com/index.php?rid=5231171&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94675%2FThrombosis%2FVTE_risk_varies_according_to_glomerulonephritis_histologic_subtype.html</link>
            <description>The risk for venous thromboembolism in patients with idiopathic glomerulonephritis is closely associated with the underlying histologic diagnosis, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231171</comments>
            <pubDate>Mon, 19 Sep 2011 16:19:48 +0100</pubDate>
            <guid isPermaLink="false">5231171</guid>        </item>
        <item>
            <title>Prasugrel more effective than double-dose clopidogrel at reducing platelet reactivity</title>
            <link>http://www.medworm.com/index.php?rid=5231172&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94677%2FThrombosis%2FPrasugrel_more_effective_than_double-dose_clopidogrel_at_reducing_platelet_reactivity.html</link>
            <description>Platelet reactivity in patients with high on-treatment platelet reactivity following chronic clopidogrel therapy is more effectively inhibited by prasugrel than double clopidogrel dosing, the results of a Greek study indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231172</comments>
            <pubDate>Mon, 19 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5231172</guid>        </item>
        <item>
            <title>Self-monitoring improves anticoagulation in patients with mechanical heart valves</title>
            <link>http://www.medworm.com/index.php?rid=5231173&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94626%2FThrombosis%2FSelf-monitoring_improves_anticoagulation_in_patients_with_mechanical_heart_valves.html</link>
            <description>The quality of oral anticoagulation therapy in patients with mechanical heart valve prostheses can be improved by self-monitoring and self-management, results of a systematic review and meta-analysis show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231173</comments>
            <pubDate>Fri, 16 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5231173</guid>        </item>
        <item>
            <title>Heart disease increases short-term risk for isolated pulmonary embolism</title>
            <link>http://www.medworm.com/index.php?rid=5231174&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94605%2FThrombosis%2FHeart_disease_increases_short-term_risk_for_isolated_pulmonary_embolism.html</link>
            <description>Patients with heart disease have an increased short-term risk for venous thromboembolism, particularly isolated pulmonary embolism, compared with the general population, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5231174</comments>
            <pubDate>Thu, 15 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5231174</guid>        </item>
        <item>
            <title>Insurance status impacts acute VTE care</title>
            <link>http://www.medworm.com/index.php?rid=5216577&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94557%2FThrombosis%2FInsurance_status_impacts_acute_VTE_care.html</link>
            <description>Uninsured patients with venous thromboembolism have longer hospital stays and are more likely to return to the emergency department postdischarge than insured patients with the same condition, US research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5216577</comments>
            <pubDate>Wed, 14 Sep 2011 07:28:02 +0100</pubDate>
            <guid isPermaLink="false">5216577</guid>        </item>
        <item>
            <title>Persistently elevated D-dimer at discharge predict recurrent VTE</title>
            <link>http://www.medworm.com/index.php?rid=5216578&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94540%2FThrombosis%2FPersistently_elevated_D-dimer_at_discharge_predict_recurrent_VTE.html</link>
            <description>Persistently abnormal plasma D-dimer levels at hospital discharge have a high negative predictive value for recurrent venous thromboembolism in patients with acute pulmonary embolism, suggest study findings. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5216578</comments>
            <pubDate>Mon, 12 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5216578</guid>        </item>
        <item>
            <title>Cx37 platelet membrane regulates platelet function, thrombosis</title>
            <link>http://www.medworm.com/index.php?rid=5202071&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94510%2FThrombosis%2FCx37_platelet_membrane_regulates_platelet_function%2C_thrombosis.html</link>
            <description>Study findings show that the platelet membrane protein connexin 37 negatively regulates platelet function, implicating Cx37 genotype as a risk marker for thrombosis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5202071</comments>
            <pubDate>Sun, 11 Sep 2011 01:18:01 +0100</pubDate>
            <guid isPermaLink="false">5202071</guid>        </item>
        <item>
            <title>PE diagnostic algorithms not followed properly among clinicians</title>
            <link>http://www.medworm.com/index.php?rid=5202072&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94477%2FThrombosis%2FPE_diagnostic_algorithms_not_followed_properly_among_clinicians_.html</link>
            <description>Study findings show that the complex set of diagnostic flow charts for pulmonary embolism are often not followed properly, putting patients at risk for adverse consequences. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5202072</comments>
            <pubDate>Thu, 08 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5202072</guid>        </item>
        <item>
            <title>Catheter-directed mechanical thrombectomy feasible for severe PE</title>
            <link>http://www.medworm.com/index.php?rid=5202073&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94433%2FThrombosis%2FCatheter-directed_mechanical_thrombectomy_feasible_for_severe_PE.html</link>
            <description>Catheter-directed mechanical thrombectomy is an effective tool for primary treatment of massive pulmonary embolism and submassive pulmonary embolism, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5202073</comments>
            <pubDate>Tue, 06 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5202073</guid>        </item>
        <item>
            <title>Mild hereditary thrombophilias raise oral contraceptive related VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5194460&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94402%2FThrombosis%2FMild_hereditary_thrombophilias_raise_oral_contraceptive_related_VTE_risk_.html</link>
            <description>Women with a factor V Leiden or prothrombin-20210A mutation have a higher risk for venous thromboembolism from using oral contraceptives than women without such mutations, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5194460</comments>
            <pubDate>Mon, 05 Sep 2011 10:27:55 +0100</pubDate>
            <guid isPermaLink="false">5194460</guid>        </item>
        <item>
            <title>BIM inversely associated with stent thrombosis risk</title>
            <link>http://www.medworm.com/index.php?rid=5189652&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94374%2FThrombosis%2FBIM_inversely_associated_with_stent_thrombosis_risk.html</link>
            <description>People with a high body mass index may have a lower risk for stent thrombosis than those with a low body mass index, Danish researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5189652</comments>
            <pubDate>Sat, 03 Sep 2011 23:42:20 +0100</pubDate>
            <guid isPermaLink="false">5189652</guid>        </item>
        <item>
            <title>Prolonged dual antiplatelet therapy unnecessary after stenting</title>
            <link>http://www.medworm.com/index.php?rid=5189653&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94312%2FThrombosis%2FProlonged_dual_antiplatelet_therapy_unnecessary_after_stenting_.html</link>
            <description>Prolonged antiplatelet therapy is unnecessary for preventing adverse cardiovascular events after stenting and may be harmful, suggest results from the PRODIGY trial. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5189653</comments>
            <pubDate>Thu, 01 Sep 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5189653</guid>        </item>
        <item>
            <title>Troponin-T predicts PE outcome</title>
            <link>http://www.medworm.com/index.php?rid=5173386&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94254%2FThrombosis%2FTroponin-T_predicts_PE_outcome.html</link>
            <description>An elevated cardiac troponin-T level significantly predicts in-hospital and long-term mortality in elderly patients presenting with acute pulmonary embolism, researchers in Australia report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173386</comments>
            <pubDate>Tue, 30 Aug 2011 00:21:38 +0100</pubDate>
            <guid isPermaLink="false">5173386</guid>        </item>
        <item>
            <title>Thromoboprophylaxis should last at least 4 weeks in stroke patients</title>
            <link>http://www.medworm.com/index.php?rid=5167549&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94228%2FThrombosis%2FThromoboprophylaxis_should_last_at_least_4_weeks_in_stroke_patients.html</link>
            <description>UK researchers report on the characteristics of deep vein thrombosis that develops after stroke and suggest that prophylaxis should be started early and continue for at least 4 weeks. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5167549</comments>
            <pubDate>Sat, 27 Aug 2011 23:34:54 +0100</pubDate>
            <guid isPermaLink="false">5167549</guid>        </item>
        <item>
            <title>LMWH alone or with warfarin effectively treats upper extremity DVT</title>
            <link>http://www.medworm.com/index.php?rid=5153255&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94191%2FThrombosis%2FLMWH_alone_or_with_warfarin_effectively_treats_upper_extremity_DVT.html</link>
            <description>US study data show that the low molecular weight heparin dalteparin, used alone or in combination with warfarin, effectively prevents recurrent venous thromboembolism in patients with upper extremity deep vein thrombosis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153255</comments>
            <pubDate>Thu, 25 Aug 2011 00:23:44 +0100</pubDate>
            <guid isPermaLink="false">5153255</guid>        </item>
        <item>
            <title>Superficial vein thrombosis may increase VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5153256&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94136%2FThrombosis%2FSuperficial_vein_thrombosis_may_increase_VTE_risk.html</link>
            <description>Clinically diagnosed superficial vein thrombosis is associated with an increased risk for venous thromboembolism, show results of a population-based study conducted in the Netherlands. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153256</comments>
            <pubDate>Tue, 23 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153256</guid>        </item>
        <item>
            <title>Thrombophilia screening should be population-specific</title>
            <link>http://www.medworm.com/index.php?rid=5153257&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94112%2FThrombosis%2FThrombophilia_screening_should_be_population-specific.html</link>
            <description>Thrombophilia screening should be restricted to testing for protein C, protein S, and antithrombin III deficiencies in people from Singapore and countries with similar demographics, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153257</comments>
            <pubDate>Mon, 22 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153257</guid>        </item>
        <item>
            <title>Pregnancy related DVT impacts future quality of life</title>
            <link>http://www.medworm.com/index.php?rid=5153258&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94089%2FThrombosis%2FPregnancy_related_DVT_impacts_future_quality_of_life.html</link>
            <description>Women with pregnancy-related deep vein thrombosis report worse long-term quality of life than women who do not develop the condition during pregnancy, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153258</comments>
            <pubDate>Fri, 19 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153258</guid>        </item>
        <item>
            <title>New risk tool identifies patients at risk for developing clots</title>
            <link>http://www.medworm.com/index.php?rid=5153259&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F94042%2FThrombosis%2FNew_risk_tool_identifies_patients_at_risk_for_developing_clots.html</link>
            <description>UK researchers have developed and validated a new risk prediction tool for venous thromboembolism in a primary care setting. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5153259</comments>
            <pubDate>Thu, 18 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5153259</guid>        </item>
        <item>
            <title>DVT incidence low after general surgery with thromboprophylaxis</title>
            <link>http://www.medworm.com/index.php?rid=5136629&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93993%2FThrombosis%2FDVT_incidence_low_after_general_surgery_with_thromboprophylaxis.html</link>
            <description>The incidence of deep vein thrombosis after general surgical operations is low when appropriate prophylaxis is used, US research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5136629</comments>
            <pubDate>Wed, 17 Aug 2011 14:17:20 +0100</pubDate>
            <guid isPermaLink="false">5136629</guid>        </item>
        <item>
            <title>Pharmacist-directed anticoagulation service improves warfarin care</title>
            <link>http://www.medworm.com/index.php?rid=5129318&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93976%2FThrombosis%2FPharmacist-directed_anticoagulation_service_improves_warfarin_care.html</link>
            <description>Implementation of a pharmacist-directed anticoagulation service improves the transition of patients on warfarin from the inpatient to outpatient setting, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5129318</comments>
            <pubDate>Mon, 15 Aug 2011 20:43:15 +0100</pubDate>
            <guid isPermaLink="false">5129318</guid>        </item>
        <item>
            <title>CYP2C19 variants do not influence clopidogrel efficacy</title>
            <link>http://www.medworm.com/index.php?rid=5123624&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93945%2FThrombosis%2FCYP2C19_variants_do_not_influence_clopidogrel_efficacy.html</link>
            <description>Polymorphisms in the cytochrome P450 2C19 gene do not influence the clinical efficacy of clopidogrel, results of a systematic review and meta-analysis show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5123624</comments>
            <pubDate>Sat, 13 Aug 2011 05:24:46 +0100</pubDate>
            <guid isPermaLink="false">5123624</guid>        </item>
        <item>
            <title>ESC model trumps PESI for pulmonary embolism prognostication</title>
            <link>http://www.medworm.com/index.php?rid=5115498&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93919%2FThrombosis%2FESC_model_trumps_PESI_for_pulmonary_embolism_prognostication.html</link>
            <description>A European Society of Cardiology prognostic model for pulmonary embolism is more accurate than the Pulmonary Embolism Severity Index for identifying high-risk patients who require prompt and aggressive treatment, Italian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115498</comments>
            <pubDate>Thu, 11 Aug 2011 15:36:52 +0100</pubDate>
            <guid isPermaLink="false">5115498</guid>        </item>
        <item>
            <title>ROCKET AF published: Rivaroxaban noninferior to warfarin</title>
            <link>http://www.medworm.com/index.php?rid=5115499&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93922%2FThrombosis%2FROCKET_AF_published_Rivaroxaban_noninferior_to_warfarin.html</link>
            <description>The ROCKET AF trial appears in print, confirming the noninferiority of rivaroxaban to warfarin for prevention of stroke and systemic embolism in patients with atrial fibrillation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115499</comments>
            <pubDate>Thu, 11 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5115499</guid>        </item>
        <item>
            <title>Sibling history may predict VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5115500&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93863%2FThrombosis%2FSibling_history_may_predict_VTE_risk.html</link>
            <description>A sibling history of venous thromboembolism appears to be an important risk factor for developing the condition, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5115500</comments>
            <pubDate>Tue, 09 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5115500</guid>        </item>
        <item>
            <title>Chromogenic assay measures apixaban activity in plasma</title>
            <link>http://www.medworm.com/index.php?rid=5105659&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93836%2FThrombosis%2FChromogenic_assay_measures_apixaban_activity_in_plasma.html</link>
            <description>A commercially available factor Xa chromogenic assay can be used to reliably measure plasma levels of apixaban, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5105659</comments>
            <pubDate>Mon, 08 Aug 2011 11:24:33 +0100</pubDate>
            <guid isPermaLink="false">5105659</guid>        </item>
        <item>
            <title>LMWH superior to UFH for primary PCI patients</title>
            <link>http://www.medworm.com/index.php?rid=5101721&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93802%2FThrombosis%2FLMWH_superior_to_UFH_for_primary_PCI_patients_.html</link>
            <description>Low molecular weight heparin is associated with reduced mortality and bleeding compared with unfractionated heparin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction, research shows. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5101721</comments>
            <pubDate>Sun, 07 Aug 2011 02:42:10 +0100</pubDate>
            <guid isPermaLink="false">5101721</guid>        </item>
        <item>
            <title>Age should not be a barrier to VKA treatment in AF, VTE</title>
            <link>http://www.medworm.com/index.php?rid=5092671&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93745%2FThrombosis%2FAge_should_not_be_a_barrier_to_VKA_treatment_in_AF%2C_VTE.html</link>
            <description>Old age alone does not contraindicate anticoagulation with vitamin K antagonists among patients with venous thromboembolism or atrial fibrillation, Italian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5092671</comments>
            <pubDate>Thu, 04 Aug 2011 10:16:56 +0100</pubDate>
            <guid isPermaLink="false">5092671</guid>        </item>
        <item>
            <title>Enoxaparin standard dose may be inappropriate in morbidly obese patients</title>
            <link>http://www.medworm.com/index.php?rid=5101722&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93803%2FThrombosis%2FEnoxaparin_standard_dose_may_be_inappropriate_in_morbidly_obese_patients.html</link>
            <description>Enoxaparin doses based on actual body weight at the recommended does of 1.0 mg/kg may not be appropriate for anticoagulation in morbidly obese patients, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5101722</comments>
            <pubDate>Thu, 04 Aug 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5101722</guid>        </item>
        <item>
            <title>Novel ‘nanobody’ shows antithrombotic potential</title>
            <link>http://www.medworm.com/index.php?rid=5084397&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93716%2FThrombosis%2FNovel_%E2%80%98nanobody%E2%80%99_shows_antithrombotic_potential.html</link>
            <description>ALX-0081, a novel nanobody that targets the von Willebrand factor glycoprotein Ib platelet binding site, may be an effective alternative to current antithrombotic drugs for patients undergoing percutaneous coronary intervention, preclinical study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5084397</comments>
            <pubDate>Tue, 02 Aug 2011 01:42:22 +0100</pubDate>
            <guid isPermaLink="false">5084397</guid>        </item>
        <item>
            <title>N-terminal of ADAMTS13 essential for arterial thrombosis inhibition</title>
            <link>http://www.medworm.com/index.php?rid=5074972&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93693%2FThrombosis%2FN-terminal_of_ADAMTS13_essential_for_arterial_thrombosis_inhibition.html</link>
            <description>The amino terminus of the metalloprotease ADAMTS13 has a crucial role in the modulation of arterial thromboses, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5074972</comments>
            <pubDate>Fri, 29 Jul 2011 23:10:58 +0100</pubDate>
            <guid isPermaLink="false">5074972</guid>        </item>
        <item>
            <title>Thrombin generation increased in hormone therapy users</title>
            <link>http://www.medworm.com/index.php?rid=5074973&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93655%2FThrombosis%2FThrombin_generation_increased_in_hormone_therapy_users.html</link>
            <description>Women using hormone therapy have increased thrombin generation, which varies according to both the route of estrogen administration and the type of progestogen used, French researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5074973</comments>
            <pubDate>Thu, 28 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5074973</guid>        </item>
        <item>
            <title>Dabigatran may reduce recurrent VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=5067452&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93607%2FThrombosis%2FDabigatran_may_reduce_recurrent_VTE_risk.html</link>
            <description>Extended anticoagulation with dabigatran reduces the risk for recurrent venous thromboembolism versus placebo in patients who have already received up to 18 months of conventional anticoagulation therapy, researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5067452</comments>
            <pubDate>Wed, 27 Jul 2011 11:52:51 +0100</pubDate>
            <guid isPermaLink="false">5067452</guid>        </item>
        <item>
            <title>High-dose rivaroxaban feasible after mechanical heart valve replacement</title>
            <link>http://www.medworm.com/index.php?rid=5060842&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93580%2FThrombosis%2FHigh-dose_rivaroxaban_feasible_after_mechanical_heart_valve_replacement.html</link>
            <description>High-dose rivaroxaban may offer an alternative to standard anticoagulation with oral vitamin K antagonists for patients with mechanical heart valves, in vitro study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5060842</comments>
            <pubDate>Mon, 25 Jul 2011 17:32:17 +0100</pubDate>
            <guid isPermaLink="false">5060842</guid>        </item>
        <item>
            <title>Factors predicting thrombus formation after stenting identified</title>
            <link>http://www.medworm.com/index.php?rid=5056539&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93552%2FThrombosis%2FFactors_predicting_thrombus_formation_after_stenting_identified.html</link>
            <description>Japanese researchers have identified the factors that most significantly predict risk for long-term thrombus formation after stent implantation. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5056539</comments>
            <pubDate>Sun, 24 Jul 2011 01:53:07 +0100</pubDate>
            <guid isPermaLink="false">5056539</guid>        </item>
        <item>
            <title>Change in vena cava filter use ‘not supported by science’</title>
            <link>http://www.medworm.com/index.php?rid=5046478&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93521%2FThrombosis%2FChange_in_vena_cava_filter_use_%E2%80%98not_supported_by_science%E2%80%99.html</link>
            <description>Vena cava filters are being used for an increasing number of reasons, despite a lack of supporting evidence, researchers believe. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046478</comments>
            <pubDate>Thu, 21 Jul 2011 21:50:32 +0100</pubDate>
            <guid isPermaLink="false">5046478</guid>        </item>
        <item>
            <title>Simple test confirms chronic thromboembolic pulmonary hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5046479&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93472%2FThrombosis%2FSimple_test_confirms_chronic_thromboembolic_pulmonary_hypertension.html</link>
            <description>Researchers have constructed an algorithm that simply and accurately rules out chronic thromboembolic pulmonary hypertension, without the need for invasive testing, in acute pulmonary embolism patients. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046479</comments>
            <pubDate>Tue, 19 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046479</guid>        </item>
        <item>
            <title>Early DVT predictors could guide prophylaxis post-stroke</title>
            <link>http://www.medworm.com/index.php?rid=5046480&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93452%2FThrombosis%2FEarly_DVT_predictors_could_guide_prophylaxis_post-stroke.html</link>
            <description>Prophylactic deep venous thrombosis treatment is “reasonable” in stroke patients with normal fibrinogen levels and increased levels of C-reactive protein, report clinicians. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5046480</comments>
            <pubDate>Mon, 18 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5046480</guid>        </item>
        <item>
            <title>Receptor controlling tissue-factor-dependent thrombosis identified</title>
            <link>http://www.medworm.com/index.php?rid=5034499&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93367%2FThrombosis%2FReceptor_controlling_tissue-factor-dependent_thrombosis_identified.html</link>
            <description>Researchers have identified a receptor that is essential to regulation of tissue factor production in thrombosis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5034499</comments>
            <pubDate>Sun, 17 Jul 2011 16:18:31 +0100</pubDate>
            <guid isPermaLink="false">5034499</guid>        </item>
        <item>
            <title>Methods for controlling pulmonary embolism needed in Africa</title>
            <link>http://www.medworm.com/index.php?rid=5025706&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93368%2FThrombosis%2FMethods_for_controlling_pulmonary_embolism_needed_in_Africa.html</link>
            <description>Pulmonary embolism is “not uncommon” in Sub-Saharan Africa and control methods are necessary, say the authors of a study investigating the epidemiology and management of disease in this region. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5025706</comments>
            <pubDate>Thu, 14 Jul 2011 17:59:49 +0100</pubDate>
            <guid isPermaLink="false">5025706</guid>        </item>
        <item>
            <title>BMI predicts venous thromboembolism site</title>
            <link>http://www.medworm.com/index.php?rid=5015878&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93324%2FThrombosis%2FBMI_predicts_venous_thromboembolism_site.html</link>
            <description>Results from a large-scale study have shown that body mass index influences where in the body venous thromboembolism arises. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5015878</comments>
            <pubDate>Tue, 12 Jul 2011 18:29:07 +0100</pubDate>
            <guid isPermaLink="false">5015878</guid>        </item>
        <item>
            <title>Electronic VTE management tool increases prophylaxis use by up to 10%</title>
            <link>http://www.medworm.com/index.php?rid=5015879&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93313%2FThrombosis%2FElectronic_VTE_management_tool_increases_prophylaxis_use_by_up_to_10.html</link>
            <description>An electronic tool for assessing risk for venous thromboembolism increases the chance of patients being treated according to guidelines 1.44 times, study results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5015879</comments>
            <pubDate>Mon, 11 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5015879</guid>        </item>
        <item>
            <title>Novel FXIa inhibitor offers promising antithrombotic therapy</title>
            <link>http://www.medworm.com/index.php?rid=5015880&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93237%2FThrombosis%2FNovel_FXIa_inhibitor_offers_promising_antithrombotic_therapy.html</link>
            <description>Preclinical research has shown that a small-molecule selective inhibitor of factor XIa is a promising antithrombotic therapy. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5015880</comments>
            <pubDate>Fri, 08 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5015880</guid>        </item>
        <item>
            <title>Oral anticoagulant reduces blood loss during arthroplasty</title>
            <link>http://www.medworm.com/index.php?rid=5004656&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93235%2FThrombosis%2FOral_anticoagulant_reduces_blood_loss_during_arthroplasty.html</link>
            <description>Significantly less blood is lost after knee replacement when patients are treated with the oral anticoagulant dabigatran than with the low molecular weight heparin dalteparin, researchers say. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5004656</comments>
            <pubDate>Thu, 07 Jul 2011 19:12:32 +0100</pubDate>
            <guid isPermaLink="false">5004656</guid>        </item>
        <item>
            <title>Antithrombotic suspension stroke risk warning</title>
            <link>http://www.medworm.com/index.php?rid=5004658&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93201%2FThrombosis%2FAntithrombotic_suspension_stroke_risk_warning.html</link>
            <description>About 5% of strokes are associated with cessation or temporary suspension of antithrombotic therapy, suggest data from a population-based study. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5004658</comments>
            <pubDate>Tue, 05 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5004658</guid>        </item>
        <item>
            <title>Sedentary lifestyle increases PE risk in women</title>
            <link>http://www.medworm.com/index.php?rid=5004657&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93192%2FThrombosis%2FSedentary_lifestyle_increases_PE_risk_in_women.html</link>
            <description>Physical inactivity, assessed by the amount of time spent sitting down per week, is associated with an increased risk for pulmonary embolism in women, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5004657</comments>
            <pubDate>Tue, 05 Jul 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5004657</guid>        </item>
        <item>
            <title>VTE burden ‘significant’ in patients with cirrhosis</title>
            <link>http://www.medworm.com/index.php?rid=4996723&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93164%2FThrombosis%2FVTE_burden_%E2%80%98significant%E2%80%99_in_patients_with_cirrhosis.html</link>
            <description>A substantial proportion of patients with cirrhosis are hospitalized with venous thromboembolism throughout the year, US study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4996723</comments>
            <pubDate>Mon, 04 Jul 2011 21:22:03 +0100</pubDate>
            <guid isPermaLink="false">4996723</guid>        </item>
        <item>
            <title>Monocytes linked to VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=4990259&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93145%2FThrombosis%2FMonocytes_linked_to_VTE_risk.html</link>
            <description>Monocyte count and procoagulant function may be associated with risk for venous thromboembolism, data from the Tromsø study show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990259</comments>
            <pubDate>Sat, 02 Jul 2011 05:23:26 +0100</pubDate>
            <guid isPermaLink="false">4990259</guid>        </item>
        <item>
            <title>Fever linked to worse DVT outcome</title>
            <link>http://www.medworm.com/index.php?rid=4981202&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93060%2FThrombosis%2FFever_linked_to_worse_DVT_outcome.html</link>
            <description>Patients with deep vein thrombosis and fever at presentation are twice as likely to die within a month than those without fever, findings from the RIETE registry show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4981202</comments>
            <pubDate>Thu, 30 Jun 2011 03:33:05 +0100</pubDate>
            <guid isPermaLink="false">4981202</guid>        </item>
        <item>
            <title>Rivaroxaban trumps dabigatran, apixaban for VTE prophylaxis</title>
            <link>http://www.medworm.com/index.php?rid=4990260&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93117%2FThrombosis%2FRivaroxaban_trumps_dabigatran%2C_apixaban_for_VTE_prophylaxis.html</link>
            <description>Rivaroxaban may be more efficient than dabigatran and apixaban for venous thromboembolism prophylaxis in patients undergoing orthopedic surgery, indicate the results of an indirect comparison by network meta-analysis. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4990260</comments>
            <pubDate>Thu, 30 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4990260</guid>        </item>
        <item>
            <title>Outpatient anticoagulation acceptable for low-risk PE</title>
            <link>http://www.medworm.com/index.php?rid=4973822&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F93030%2FThrombosis%2FOutpatient_anticoagulation_acceptable_for_low-risk_PE.html</link>
            <description>Outpatient treatment with low molecular weight heparin is feasible in patients with low-risk pulmonary embolism, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4973822</comments>
            <pubDate>Tue, 28 Jun 2011 16:13:34 +0100</pubDate>
            <guid isPermaLink="false">4973822</guid>        </item>
        <item>
            <title>Hospital-wide VTE prevention program ‘feasible’</title>
            <link>http://www.medworm.com/index.php?rid=4966293&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92963%2FThrombosis%2FHospital-wide_VTE_prevention_program_%E2%80%98feasible%E2%80%99.html</link>
            <description>Implementation of a hospital-wide venous thromboembolism risk assessment program reduces thrombosis incidence and improves the rate of prophylaxis, US researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966293</comments>
            <pubDate>Sun, 26 Jun 2011 15:14:49 +0100</pubDate>
            <guid isPermaLink="false">4966293</guid>        </item>
        <item>
            <title>Anticoagulation for calf DVT reduces pulmonary embolism risk</title>
            <link>http://www.medworm.com/index.php?rid=4958401&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92903%2FThrombosis%2FAnticoagulation_for_calf_DVT_reduces_pulmonary_embolism_risk_.html</link>
            <description>Patients who receive anticoagulation for calf deep venous thrombosis have significantly lower rates of pulmonary embolism and clot propagation than those who do not receive such treatment, results of a meta-analysis show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4958401</comments>
            <pubDate>Thu, 23 Jun 2011 03:11:46 +0100</pubDate>
            <guid isPermaLink="false">4958401</guid>        </item>
        <item>
            <title>Open colorectal surgery confers higher VTE risk than laparoscopy</title>
            <link>http://www.medworm.com/index.php?rid=4966294&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92962%2FThrombosis%2FOpen_colorectal_surgery_confers_higher_VTE_risk_than_laparoscopy.html</link>
            <description>The risk for perioperative venous thromboembolism is nearly twice as high among patients who undergo open colorectal surgery compared with those who are treated laparoscopically, research suggests. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4966294</comments>
            <pubDate>Thu, 23 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4966294</guid>        </item>
        <item>
            <title>Thrombocytopenia more common with UFH than LMWH</title>
            <link>http://www.medworm.com/index.php?rid=4950471&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92872%2FThrombosis%2FThrombocytopenia_more_common_with_UFH_than_LMWH.html</link>
            <description>Thrombocytopenia occurs more frequently with unfractionated heparin treatment than with low molecular weight heparin, but is generally uncommon, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4950471</comments>
            <pubDate>Tue, 21 Jun 2011 15:27:00 +0100</pubDate>
            <guid isPermaLink="false">4950471</guid>        </item>
        <item>
            <title>Von Willebrand factor-associated gene variants raise thrombosis risk</title>
            <link>http://www.medworm.com/index.php?rid=4943336&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92868%2FThrombosis%2FVon_Willebrand_factor-associated_gene_variants_raise_thrombosis_risk_.html</link>
            <description>Variations in two genes previously associated with plasma von Willebrand factor are independently linked to incident venous thrombosis risk, say researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4943336</comments>
            <pubDate>Sun, 19 Jun 2011 04:18:25 +0100</pubDate>
            <guid isPermaLink="false">4943336</guid>        </item>
        <item>
            <title>Updated warfarin guidelines released</title>
            <link>http://www.medworm.com/index.php?rid=4930340&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92829%2FThrombosis%2FUpdated_warfarin_guidelines_released.html</link>
            <description>The British Committee for Standards in Haematology has published updated guidelines on oral anticoagulation with warfarin. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930340</comments>
            <pubDate>Thu, 16 Jun 2011 16:48:38 +0100</pubDate>
            <guid isPermaLink="false">4930340</guid>        </item>
        <item>
            <title>Ultra-low molecular weight heparin feasible for cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=4930341&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92773%2FThrombosis%2FUltra-low_molecular_weight_heparin_feasible_for_cancer_patients.html</link>
            <description>A novel ultra-low molecular weight heparin, semuloparin, significantly reduces the risk for venous thromboembolism compared with placebo, without increasing the risk for bleeding, a study among patients with cancer has shown. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930341</comments>
            <pubDate>Tue, 14 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930341</guid>        </item>
        <item>
            <title>Hypofibrinolysis, protein C deficiency significantly increase VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=4930342&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92744%2FThrombosis%2FHypofibrinolysis%2C_protein_C_deficiency_significantly_increase_VTE_risk.html</link>
            <description>Increased clot lysis time combined with protein C deficiency is associated with a substantially increased risk for venous thromboembolism, study data show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4930342</comments>
            <pubDate>Mon, 13 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4930342</guid>        </item>
        <item>
            <title>Thrombus resolution of DVT hampered by IFN-gamma</title>
            <link>http://www.medworm.com/index.php?rid=4918830&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92720%2FThrombosis%2FThrombus_resolution_of_DVT_hampered_by_IFN-gamma.html</link>
            <description>Interferon-gamma may be associated with increased thrombus size and may delay thrombus resolution in deep vein thrombosis, say Japanese scientists who suggest it may represent a molecular target for the prevention of thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4918830</comments>
            <pubDate>Sat, 11 Jun 2011 00:34:23 +0100</pubDate>
            <guid isPermaLink="false">4918830</guid>        </item>
        <item>
            <title>Elevated gas6 levels may increase VTE risk</title>
            <link>http://www.medworm.com/index.php?rid=4918831&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92670%2FThrombosis%2FElevated_gas6_levels_may_increase_VTE_risk.html</link>
            <description>Canadian researchers have shown that patients with high levels of the growth arrest-specific 6 protein have a considerably increased risk for venous thromboembolism. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4918831</comments>
            <pubDate>Thu, 09 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4918831</guid>        </item>
        <item>
            <title>Novel imaging technique used for DVT detection</title>
            <link>http://www.medworm.com/index.php?rid=4909302&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92624%2FThrombosis%2FNovel_imaging_technique_used_for_DVT_detection.html</link>
            <description>US researchers have developed a novel peptide that targets fibrin and enables clots to be detected by near-infrared fluorescence imaging. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909302</comments>
            <pubDate>Wed, 08 Jun 2011 21:02:47 +0100</pubDate>
            <guid isPermaLink="false">4909302</guid>        </item>
        <item>
            <title>Patients on hemodialysis have elevated HIT risk</title>
            <link>http://www.medworm.com/index.php?rid=4900125&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92558%2FThrombosis%2FPatients_on_hemodialysis_have_elevated_HIT_risk__.html</link>
            <description>In-patients who receive heparin during a hospital stay face an increased risk for heparin-induced thrombocytopenia if they are currently on scheduled hemodialysis, have an autoimmune disease, heart failure, or gout, study results show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4900125</comments>
            <pubDate>Mon, 06 Jun 2011 16:21:01 +0100</pubDate>
            <guid isPermaLink="false">4900125</guid>        </item>
        <item>
            <title>Thrombosis risk factors identified in essential thrombocythemia</title>
            <link>http://www.medworm.com/index.php?rid=4909303&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92602%2FThrombosis%2FThrombosis_risk_factors_identified_in_essential_thrombocythemia.html</link>
            <description>Venous and arterial thromboses have different risk factors among patients with essential thrombocythemia, study findings indicate. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4909303</comments>
            <pubDate>Mon, 06 Jun 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4909303</guid>        </item>
        <item>
            <title>VTE prophylaxis ‘unacceptably low’ in the Middle East</title>
            <link>http://www.medworm.com/index.php?rid=4890094&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92545%2FThrombosis%2FVTE_prophylaxis_%E2%80%98unacceptably_low%E2%80%99_in_the_Middle_East.html</link>
            <description>Compliance with venous thromboembolism prophylaxis guidelines is “unacceptably low” in patients hospitalized in the Middle East, results of an international study show. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4890094</comments>
            <pubDate>Fri, 03 Jun 2011 04:46:54 +0100</pubDate>
            <guid isPermaLink="false">4890094</guid>        </item>
        <item>
            <title>Nurse educator improves VTE prophylaxis rates</title>
            <link>http://www.medworm.com/index.php?rid=4882161&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92479%2FThrombosis%2FNurse_educator_improves_VTE_prophylaxis_rates.html</link>
            <description>Use of venous thromboembolism prophylaxis among hospitalized medical patients can be significantly improved by implementation of a nurse-led educational program, Australian researchers report. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4882161</comments>
            <pubDate>Tue, 31 May 2011 21:32:21 +0100</pubDate>
            <guid isPermaLink="false">4882161</guid>        </item>
        <item>
            <title>Omega-3 polyunsaturated fatty acids have ‘novel antithrombotic effects’</title>
            <link>http://www.medworm.com/index.php?rid=4869449&amp;cid=s_36327_49_f&amp;fid=36327&amp;url=http%3A%2F%2Fwww.medwire-news.md%2F62%2F92452%2FThrombosis%2FOmega-3_polyunsaturated_fatty_acids_have_%E2%80%98novel_antithrombotic_effects%E2%80%99.html</link>
            <description>Omega-3 polyunsaturated fatty acids, combined with dual antiplatelet therapy, can significantly decrease thrombin formation and oxidative stress, and favorably alter fibrin clot properties, say researchers. (Source: MedWire News - Thrombosis)</description>
            <author>MedWire News - Thrombosis</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4869449</comments>
            <pubDate>Fri, 27 May 2011 21:11:03 +0100</pubDate>
            <guid isPermaLink="false">4869449</guid>        </item>
    </channel>
</rss>

